Tonix Pharmaceuticals Holding Corp.
TNXP Nasdaq
SEC CIK 1430306
Follow Tonix Pharmaceuticals Holding Corp.
Weekly email: filings, results
Revenue, last quarter
$17.2M
+423.8% vs same quarter last year
Net income
−$53.3M
−66.6% vs same quarter last year
EPS, diluted
−$2.89
+19.5% vs same quarter last year
Operating cash flow
−$41.1M
−42.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $13.1M | −$124M |
| FY24 | $10.1M | −$130M |
| FY23 | $7.8M | −$116.7M |
| FY22 | - | −$110.2M |
| FY21 | - | −$92.3M |
| FY20 | - | −$50.5M |
| FY19 | - | −$28.6M |
| FY18 | - | −$26.1M |
| FY17 | - | −$21.1M |
| FY16 | - | −$38.8M |
| FY15 | - | −$48.1M |
| FY14 | - | −$27.6M |
| FY13 | - | −$10.9M |
| FY12 | - | −$9.5M |
| FY11 | - | −$3.5M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 49.3% | −959.1% | −946.2% |
| FY24 | 23.1% | −1354.3% | −1288.3% |
| FY23 | 39% | −1523.9% | −1501.8% |
| FY22 | - | - | - |
| FY21 | - | - | - |
| FY20 | - | - | - |
| FY19 | - | - | - |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$103.2M |
| FY24 | −$61M |
| FY23 | −$109.9M |
| FY22 | −$146.2M |
| FY21 | −$110.9M |
| FY20 | −$57.1M |
| FY19 | −$26.7M |
| FY18 | −$24M |
| FY17 | −$19.1M |
| FY16 | −$37.4M |
| FY15 | −$42.6M |
| FY14 | −$23.2M |
| FY13 | −$8.5M |
| FY12 | −$5.7M |
| FY11 | −$2.6M |
- Tonix Pharmaceuticals Holding Corp.
- Healthcare median
Show the numbers
| Year | Tonix Pharmaceuticals Holding Corp. | Healthcare median |
|---|---|---|
| FY25 | −946.2% | −30.6% |
| FY24 | −1288.3% | −47% |
| FY23 | −1501.8% | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.9% |
| FY20 | - | −62.2% |
| FY19 | - | −46.3% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |